Published in Surgery Litigation and Law Weekly, June 3rd, 2005
The Exogen Bone Healing system delivers low-intensity pulsed ultrasound to a fracture site, and is the only ultrasound stimulation device approved by the U.S. Food and Drug Administration (FDA) for the treatment of nonunion fractures. In addition, the Exogen system is the only osteogenic bone stimulator of any kind approved by the FDA for accelerating the healing of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.